Imbed Biosciences Inc.

Imbed Biosciences Inc. is a privately held medical device manufacturer headquartered in Middleton, Wisconsin, specializing in advanced wound care solutions. The company develops and markets the SAM™ (Synthetic Antimicrobial Matrix) platform technology—a patented, fully synthetic, biocompatible, bioresorbable matrix designed to integrate multiple wound care agents into an ultra-thin polymer formulation. The SAM™ technology is non-toxic, broad-spectrum antimicrobial through integrated silver, and naturally conforms to wound bed anatomy. Current product portfolio includes Surgaflex™ (acute and surgical wounds), Pelashield™ (burn wounds), and Microlyte® (chronic wounds). Recent portfolio expansion includes SAM™ PainGuard™ variants (Surgaflex™ PainGuard™, Pelashield™ PainGuard™, Microlyte® PainGuard™) that incorporate lidocaine HCl for non-opioid localized pain management alongside antimicrobial protection. Products are indicated for chronic ulcers, surgical wounds, traumatic injuries, and burn wounds across multiple care settings including hospitals, ambulatory surgery centers, physician offices, burn centers, and wound centers. Imbed is registered with the U.S. FDA as a medical device manufacturer and maintains ISO 13485:2016 certification. The company actively supports healthcare providers through education, testimonials, and industry engagement, with recent CMS HCPCS code assignment (A2040) for Microlyte® PainGuard™ enabling standardized billing and claims reporting.